Kobayashi Pharmaceutical Co Ltd
TSE:4967

Watchlist Manager
Kobayashi Pharmaceutical Co Ltd Logo
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Watchlist
Price: 5 407 JPY 0.39% Market Closed
Market Cap: ¥402B

Operating Margin

11.9%
Current
Declining
by 2.8%
vs 3-y average of 14.7%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
11.9%
=
Operating Income
¥19.4B
/
Revenue
¥163.2B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
11.9%
=
Operating Income
¥19.4B
/
Revenue
¥163.2B

Peer Comparison

Country Company Market Cap Operating
Margin
JP
Kobayashi Pharmaceutical Co Ltd
TSE:4967
401.9B JPY
Loading...
FR
L'Oreal SA
PAR:OR
206.2B EUR
Loading...
UK
Unilever PLC
LSE:ULVR
121B GBP
Loading...
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.6T INR
Loading...
UK
HALEON PLC
LSE:HLN
33.9B GBP
Loading...
US
Estee Lauder Companies Inc
NYSE:EL
41.2B USD
Loading...
DE
Beiersdorf AG
XETRA:BEI
22B EUR
Loading...
JP
Kao Corp
TSE:4452
2.8T JPY
Loading...
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.2T INR
Loading...
IN
Dabur India Ltd
NSE:DABUR
895B INR
Loading...
CA
Relevium Technologies Inc
XTSX:RLV
12.2B CAD
Loading...

Market Distribution

Higher than 75% of companies in Japan
Percentile
75th
Based on 6 730 companies
75th percentile
11.9%
Low
-125 500% — 4.2%
Typical Range
4.2% — 10.6%
High
10.6% — 9 743.7%
Distribution Statistics
Japan
Min -125 500%
30th Percentile 4.2%
Median 7%
70th Percentile 10.6%
Max 9 743.7%

Kobayashi Pharmaceutical Co Ltd
Glance View

Market Cap
402B JPY
Industry
Consumer products

In the bustling landscape of Japanese business, Kobayashi Pharmaceutical Co., Ltd. stands as an epitome of innovation and tradition. Founded in 1886, this company, steeped in history, has consistently demonstrated a knack for transforming simple consumer needs into thriving business opportunities. Core to its operations is the development, manufacturing, and marketing of consumer healthcare products that subtly blend pharmaceutical expertise with daily convenience. This approach has allowed Kobayashi Pharmaceutical to carve out a distinctive niche, particularly in over-the-counter (OTC) health and personal care products. The company's vast array of products is remarkably diverse, ranging from cooling gel sheets for fevers to herbal medicinal drinks, each crafted with an understanding of consumer pain points and a commitment to well-being. What sets Kobayashi apart in the competitive market is its strategic focus on niche products that serve unmet needs. This laser-sharp business model does more than just bolster its domestic market; it drives its global expansion into key markets in Asia, North America, and Europe. The company's profitability hinges not just on innovation but also on its agile response to the shifting preferences of health-conscious consumers. Driven by a mission to deliver "small but valuable products," Kobayashi’s nimble approach, coupled with an impressive R&D focus, ensures that it remains at the forefront of both consumer satisfaction and shareholder value. Much like a well-crafted Japanese garden, every part of Kobayashi's operation is meticulously designed to function harmoniously, making it a standout player in the global consumer healthcare industry.

Intrinsic Value
5 462.13 JPY
Undervaluation 1%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
11.9%
=
Operating Income
¥19.4B
/
Revenue
¥163.2B
What is Kobayashi Pharmaceutical Co Ltd's current Operating Margin?

The current Operating Margin for Kobayashi Pharmaceutical Co Ltd is 11.9%, which is below its 3-year median of 14.7%.

How has Operating Margin changed over time?

Over the last 3 years, Kobayashi Pharmaceutical Co Ltd’s Operating Margin has decreased from 15.7% to 11.9%. During this period, it reached a low of 11.9% on Sep 30, 2025 and a high of 16.1% on Jun 30, 2023.

Back to Top